Royal Fund Management, LLC Abbott Laboratories Transaction History

Royal Fund Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	BUY	$109.52 - $120.96 $194,836 - $215,187	1,779 New	1,779 $202,000
Q2 2020 Aug 06, 2020	SELL	$76.57 - $98.0 $22,664 - $29,008	-296 Closed	0 $0
Q1 2020 May 08, 2020	SELL	$62.82 - $91.86 $1,633 - $2,388	-26 Reduced 8.07%	296 $23,000
Q4 2019 May 11, 2020	BUY	$78.51 - $87.4 $2,041 - $2,272	26 Added 8.78%	322 $27,000
Q3 2018 May 07, 2020	SELL	$60.81 - $73.36 $1,094 - $1,320	-18 Reduced 5.73%	296 $21,000
Q2 2018 May 07, 2020	SELL	$57.57 - $63.54 $4,432 - $4,892	-77 Reduced 19.69%	314 $19,000
Q1 2018 May 07, 2020	BUY	$56.27 - $63.62 $1,012 - $1,145	18 Added 4.83%	391 $23,000
Q3 2017 May 07, 2020	SELL	$48.06 - $53.64 $4,421 - $4,934	-92 Reduced 19.78%	373 $19,000
Q2 2017 May 07, 2020	SELL	N/A	-1,516 Reduced 76.53%	465 $22,000
Q1 2017 May 07, 2020	SELL	N/A	-66 Reduced 3.22%	1,981 $87,000
Q4 2016 May 07, 2020	BUY	N/A	2,047	2,047 $78,000

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Royal Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Royal Fund Management, LLC with notifications on news.